InsiderTrades.com logo
Trump won. Buy this coin now.
From Weiss Ratings   |   Ad
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
This could be his favorite coin.
Joseph S. Zakrzewski net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Joseph Zakrzewski Biography and Net Worth

Director of Acceleron Pharma
Joseph S. Zakrzewski has served as a member of Sangamo's Board of Directors since June 2017. Mr. Zakrzewski has over 25 years of experience in the biopharmaceutical industry with senior leadership experience in R&D, supply chain and manufacturing operations, business development and commercialization. From 2010 through 2013, he was Chairman and CEO of Amarin Pharmaceuticals, where he led the development and commercialization of the company's first product, Vascepa. Mr. Zakrzewski previously served as a Venture Partner with Orbimed Advisors, a venture capital firm, and as Chairman, President and CEO of Xcellerex, a privately held company focused on the commercialization of its proprietary manufacturing technology for biotherapeutics and vaccines. Earlier, he served as COO of Reliant Pharmaceuticals before its acquisition by GlaxoSmithKline in 2007 and held various executive positions at Eli Lilly & Company in the areas of R&D, manufacturing, finance and business development. Mr. Zakrzewski currently serves as a member of the board of directors of various public and private companies, including Acceleron Pharma, Amarin Pharmaceuticals Insulet Corporation and Onxeo SA where he serves as Chairman. Mr. Zakrzewski received a B.S. in Chemical Engineering and an M.S. in Biochemical Engineering from Drexel University, and an M.B.A. in Finance from Indiana University.

What is Joseph S. Zakrzewski's net worth?

The estimated net worth of Joseph S. Zakrzewski is at least $72.55 million as of January 18th, 2024. Mr. Zakrzewski owns 405,880 shares of Acceleron Pharma stock worth more than $72,551,050 as of November 19th. This net worth evaluation does not reflect any other investments that Mr. Zakrzewski may own. Learn More about Joseph S. Zakrzewski's net worth.

How do I contact Joseph S. Zakrzewski?

The corporate mailing address for Mr. Zakrzewski and other Acceleron Pharma executives is 128 SYDNEY STREET, CAMBRIDGE MA, 02139. Acceleron Pharma can also be reached via phone at (617) 649-9200 and via email at [email protected]. Learn More on Joseph S. Zakrzewski's contact information.

Has Joseph S. Zakrzewski been buying or selling shares of Acceleron Pharma?

Joseph S. Zakrzewski has not been actively trading shares of Acceleron Pharma within the last three months. Most recently, Joseph S. Zakrzewski sold 10,000 shares of the business's stock in a transaction on Monday, April 5th. The shares were sold at an average price of $140.73, for a transaction totalling $1,407,300.00. Following the completion of the sale, the director now directly owns 44,499 shares of the company's stock, valued at $6,262,344.27. Learn More on Joseph S. Zakrzewski's trading history.

Who are Acceleron Pharma's active insiders?

Acceleron Pharma's insider roster includes Habib Dable (CEO), Sujay Kango (EVP), Terrence Kearney (Director), Thomas McCourt (Director), Kevin McLaughlin (CFO), Adam Veness (SVP), and Joseph Zakrzewski (Director). Learn More on Acceleron Pharma's active insiders.

Joseph S. Zakrzewski Insider Trading History at Acceleron Pharma

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/5/2021Sell10,000$140.73$1,407,300.0044,499View SEC Filing Icon  
4/1/2021Sell10,000$134.64$1,346,400.0044,499View SEC Filing Icon  
6/14/2019Buy5,000$38.05$190,250.0012,750View SEC Filing Icon  
12/30/2016Buy4,000$25.50$102,000.004,000View SEC Filing Icon  
See Full Table

Joseph S. Zakrzewski Buying and Selling Activity at Acceleron Pharma

This chart shows Joseph S Zakrzewski's buying and selling at Acceleron Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Acceleron Pharma Company Overview

Acceleron Pharma logo
Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA.
Read More

Today's Range

Now: $178.75
Low: $178.75
High: $178.75

50 Day Range

MA: $176.25
Low: $172.08
High: $179.68

2 Week Range

Now: $178.75
Low: $108.82
High: $189.99

Volume

N/A

Average Volume

572,759 shs

Market Capitalization

$10.93 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.13
Trump won. Buy this coin now.
From Weiss Ratings   |   Ad
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
This could be his favorite coin.